Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines

被引：407

作者：

Gralla, RJ ^{[1
]}

Osoba, D ^{[1
]}

Kris, MG ^{[1
]}

Kirkbride, P ^{[1
]}

Hesketh, PJ ^{[1
]}

Chinnery, LW ^{[1
]}

Clark-Snow, R ^{[1
]}

Gill, DP ^{[1
]}

Groshen, S ^{[1
]}

Grunberg, S ^{[1
]}

Koeller, JM ^{[1
]}

Morrow, GR ^{[1
]}

Perez, EA ^{[1
]}

Silber, JH ^{[1
]}

Pfister, DG ^{[1
]}

机构：

[1] Amer Soc Clin Oncol, Alexandria, VA 22314 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1999年 / 17卷 / 09期

关键词：

D O I：

10.1200/JCO.1999.17.9.2971

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2971 / 2994

页数：24

共 291 条

[1] METHODOLOGICAL ISSUES IN ANTIEMETIC STUDIES [J].

AAPRO, M .

INVESTIGATIONAL NEW DRUGS, 1993, 11 (04) :243-253

[2] THE INCIDENCE OF ANTICIPATORY NAUSEA AND VOMITING AFTER REPEAT CYCLE CHEMOTHERAPY - THE EFFECT OF GRANISETRON [J].

AAPRO, MS ;

KIRCHNER, V ;

TERREY, JP .

BRITISH JOURNAL OF CANCER, 1994, 69 (05) :957-960

[3]

AAPRO MS, 1981, CANCER CHEMOTH PHARM, V7, P11

[4] COSTS AND BENEFITS OF ANTIEMETIC THERAPY [J].

AAPRO, MS .

SUPPORTIVE CARE IN CANCER, 1994, 2 (05) :304-306

[5] DOUBLE-BLIND CROSSOVER STUDY OF THE ANTIEMETIC EFFICACY OF HIGH-DOSE DEXAMETHASONE VERSUS HIGH-DOSE METOCLOPRAMIDE [J].

AAPRO, MS ;

PLEZIA, PM ;

ALBERTS, DS ;

GRAHAM, V ;

JONES, SE ;

SURWIT, EA ;

MOON, TE .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :466-471

[6]

Abbott Beverly, 1996, Blood, V88, p252B

[7] PHASE-I/II TRIAL OF GRANISETRON - A NOVEL 5-HYDROXYTRYPTAMINE ANTAGONIST FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING [J].

ADDELMAN, M ;

ERLICHMAN, C ;

FINE, S ;

WARR, D ;

MURRAY, C .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (02) :337-341

[8]

AGURA ED, 1995, BONE MARROW TRANSPL, V16, P213

[9]

ALAVI JB, 1984, P AN M AM SOC CLIN, V3, P109

[10]

ALBA E, 1989, ONCOLOGY, V46, P26

← 1 2 3 4 5 6 7 8 9 10 →